Page 25 - COVID Newsletter 11 June

minutes of obtaining the patient sample. The kit has also been also supplemented with a free smartphone app to facilitate unambiguous results interpretation and automated dissemination to the patients.
Recognizing the impact of the COVIRAP technology in meeting the long-standing demands of high-quality community-level testing, IIT Kharagpur has further initiated the procedure of deploying this product for on-campus use to detect possible novel coronavirus infection.
The envisaged trade-off between the high scientific standards of advanced molecular diagnostics with the elegance of common rapid tests appears to be the future of infectious disease detection and management. A platform technology capable to be inclusive of all such disease detections where nucleic acid-based tests may be deployed, COVIRAP is not just
a one-time solution targeted specifically to COVID-19 but will remain imperative in global disease management in years to come.
Contact Info: suman@mech.iitkgp.ac.in; info@VeenaNxt.com
Website link:
https://kgpchronicle.iitkgp.ac.in/global-launch-of-covirap-nucleic-acid-based- point-of-care-diagnostic-device-by-iit-kharagpur-for-covid-19-and-beyond/
Indian Immunologicals Limited to start production of drug
substance for Covaxin under Mission COVID Suraksha
In a bid to augment the vaccine production, the Government has decided to support some public sector companies with grants under the Mission COVID Suraksha. One such company is the Hyderabad-based Indian Immunological limited (IIL), a facility under the PSU, National Dairy Development Board.
VOL. IV ISSUE 4
VIGYAN PRASAR 21
NATION’S S&T EFFORTS AGAINST COVID-19